Literature DB >> 12150328

GAD antigen and its significance in type I diabetes.

M I Hawa, R D G Leslie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12150328     DOI： 10.1007/BF03345077

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  5 in total

Review 1.  Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.

Authors:  R D Leslie; M A Atkinson; A L Notkins
Journal:  Diabetologia       Date:  1999-01       Impact factor: 10.122

2.  Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.

Authors:  M Hawa; R Rowe; M S Lan; A L Notkins; P Pozzilli; M R Christie; R D Leslie
Journal:  Diabetes       Date:  1997-08       Impact factor: 9.461

3.  Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.

Authors:  J Endl; H Otto; G Jung; B Dreisbusch; F Donie; P Stahl; R Elbracht; G Schmitz; E Meinl; M Hummel; A G Ziegler; R Wank; D J Schendel
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.

Authors:  T Lohmann; M Hawa; R D Leslie; R Lane; J Picard; M Londei
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

5.  Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice.

Authors:  J Tian; M Clare-Salzler; A Herschenfeld; B Middleton; D Newman; R Mueller; S Arita; C Evans; M A Atkinson; Y Mullen; N Sarvetnick; A J Tobin; P V Lehmann; D L Kaufman
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.